What type of treatment is erlotinib?
Erlotinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Is afatinib better than erlotinib?
This study shows that afatinib has clinical efficacy as second-line treatment for patients with squamous cell carcinoma of the lung. Afatinib reduced the risk of death compared with erlotinib and also improved progression-free survival, health-related quality-of-life outcomes, and symptom control.
What cancer is erlotinib used for?
Erlotinib is a type of targeted cancer drug, and is also known by its brand name Tarceva (pronounced tar-see-vah). It is a treatment for: non small cell lung cancer (NSCLC) that has spread (advanced) advanced pancreatic cancer – alongside the chemotherapy drug gemcitabine.
What is the most common side effect of erlotinib?
The most common adverse reactions with TARCEVA are rash and diarrhea usually with onset during the first month of treatment. The incidences of rash and diarrhea from clinical studies of TARCEVA for the treatment of NSCLC and pancreatic cancer were 70% for rash and 42% for diarrhea.
Is erlotinib a chemotherapy?
Erlotinib is a non-chemotherapy drug for the treatment of advanced or metastatic NSCLC and is administered orally once a day. It successfully inhibits EGFR, a protein involved in the growth and development of cancers.
Can erlotinib cure pancreatic cancer?
We found that overall survival in patients with advanced pancreatic cancer was significantly improved with erlotinib and gemcitabine compared with placebo plus gemcitabine; the HR of 0.82 represents a 18% reduction in the risk of death, or alternately, an overall 22% improvement in survival.
What is the medication erlotinib used for?
Erlotinib is used for the treatment of metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) gene mutations. Your doctor will perform a test before you take this medicine.
What is the cost of erlotinib?
The cost for erlotinib oral tablet 100 mg is around $6,866 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
When was erlotinib approved for pancreatic cancer?
Erlotinib taken with gemcitabine was approved by the FDA for locally advanced, inoperable, or metastatic pancreatic cancer in 2005.
What is the brand name for erlotinib?
Tarceva is the trade name for the generic drug name Erlotinib. In some cases, health care professionals may use the trade name Tarceva when referring to the generic drug name Erlotinib.
What is ererlotinib used to treat?
Erlotinib is used to treat certain types of non-small cell lung cancer that has spread to nearby tissues or to other parts of the body in patients who have already been treated with at least one other chemotherapy medication and have not gotten better.
How effective is erlotinib for the prolongation of life?
In our placebo-controlled trial, erlotinib did provide clinically meaningful prolongation of survival. According to the Kaplan–Meier estimates, the median survival was prolonged by two months, and 31 percent of patients treated with erlotinib were alive at one year, as compared with 22 percent in the placebo group.
Does ererlotinib prolong survival in lung cancer?
Erlotinib can prolong survival in patients with non–small-cell lung cancer after first-line or second-line chemotherapy.
What is the prognosis of erlotinib-induced nephrotic syndrome?
Overall survival was 6.7 months and 4.7 months, respectively (hazard ratio, 0.70; P<0.001), in favor of erlotinib. Five percent of patients discontinued erlotinib because of toxic effects.